Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Metlife Inc (MET)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,457,052
  • Shares Outstanding, K 986,838
  • Annual Sales, $ 62,308 M
  • Annual Income, $ 4,010 M
  • 36-Month Beta 1.21
  • Price/Sales 0.69
  • Price/Cash Flow 10.06
  • Price/Book 0.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.30
  • Number of Estimates 7
  • High Estimate 1.34
  • Low Estimate 1.25
  • Prior Year 1.11
  • Growth Rate Est. (year over year) +17.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.76 +19.99%
on 12/26/18
45.46 -0.33%
on 01/18/19
+5.69 (+14.36%)
since 12/18/18
3-Month
37.76 +19.99%
on 12/26/18
46.35 -2.24%
on 11/14/18
+1.69 (+3.87%)
since 10/18/18
52-Week
37.76 +19.99%
on 12/26/18
55.21 -17.93%
on 01/29/18
-7.64 (-14.43%)
since 01/18/18

Most Recent Stories

More News
MGIC Investment (MTG) Q4 Earnings Beat, Revenues Up Y/Y

MGIC Investment (MTG) Q4 results reflect lower credit losses, improved net premiums earned, and impact of lower tax and share buybacks.

MTG : 11.76 (+0.94%)
KMPR : 74.59 (+1.79%)
RDN : 18.04 (+0.78%)
MET : 45.31 (+0.58%)
Multiline Insurance Stocks Outlook: Prospects Look Promising

Multiline Insurance Stocks Outlook: Prospects Look Promising

AGESY : 46.8300 (+0.58%)
MTG : 11.76 (+0.94%)
AEG : 5.19 (+2.98%)
CI : 194.83 (+0.17%)
KMPR : 74.59 (+1.79%)
RDN : 18.04 (+0.78%)
MET : 45.31 (+0.58%)
Are Investors Undervaluing MetLife (MET) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

MET : 45.31 (+0.58%)
Here's Why You Should Add Assurant (AIZ) to Your Portfolio

Assurant (AIZ) rides on operational excellence and promises better rewards for investors.

MTG : 11.76 (+0.94%)
AIZ : 96.38 (+0.97%)
CI : 194.83 (+0.17%)
MET : 45.31 (+0.58%)
MetLife (MET) Gains As Market Dips: What You Should Know

MetLife (MET) closed at $43.72 in the latest trading session, marking a +0.81% move from the prior day.

MET : 45.31 (+0.58%)
Glancy Prongay & Murray LLP Commences Investigation On Behalf Of MetLife, Inc. Investors (MET)

Glancy Prongay & Murray LLP ("GPM") announces that it is investigating potential claims on behalf of investors of MetLife, Inc. (NYSE: MET) ("MetLife" or "the Company") and whether the Company's officers...

MET : 45.31 (+0.58%)
MetLife to Hold Conference Call for Fourth Quarter and Full Year 2018 Results

MetLife, Inc. (NYSE: MET) today announced that it will hold its fourth quarter and full year 2018 earnings conference call and audio webcast on Thursday, Feb. 7, 2019, from 9-10 a.m. (ET)....

MET : 45.31 (+0.58%)
CNO Financial's Subsidiaries Get Ratings From A.M. Best

CNO Financial's (CNO) arms receive rating actions from A.M. Best. Outlook is stable.

CNO : 17.61 (+1.21%)
CI : 194.83 (+0.17%)
KMPR : 74.59 (+1.79%)
MET : 45.31 (+0.58%)
Why MetLife (MET) is Worth Adding to Your Portfolio Now

Business streamlining and a solid balance sheet poise MetLife for growth in 2019.

MTG : 11.76 (+0.94%)
AIZ : 96.38 (+0.97%)
CNO : 17.61 (+1.21%)
MET : 45.31 (+0.58%)
Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays

Zacks.com featured expert Kevin Matras highlights: Gulfport Energy, MetLife, Fiat Chrysler Automobiles, CVS Health and Barclays

FCAU : 16.78 (+0.96%)
CVS : 65.52 (+3.39%)
BCS : 8.57 (+2.39%)
MET : 45.31 (+0.58%)
GPOR : 9.25 (+4.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade MET with:

Business Summary

MetLife, Inc. is a leading global provider of insurance, annuities and employee benefit programs, serving 90 million customers. Through its subsidiaries and affiliates, MetLife holds leading market positions in the United States, Japan, Latin America, Asia, Europe, the Middle East and Africa. MetLife...

See More

Key Turning Points

2nd Resistance Point 45.68
1st Resistance Point 45.50
Last Price 45.31
1st Support Level 45.09
2nd Support Level 44.86

See More

52-Week High 55.21
Fibonacci 61.8% 48.54
Fibonacci 50% 46.49
Last Price 45.31
Fibonacci 38.2% 44.43
52-Week Low 37.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar